SPONSORED

Skylight Health Group (TSX:SHG)(OTCQB:SHGFF) Has a Potential $290B Chance(1) To Transform Our Disastrous Health System

With a Value-Based Medicine Model, This Undervalued Disruptor Could See Its Revenue Skyrocket By 500%+(1) As it Prepares To Uplist to the Nasdaq(2)

News Update: June 2, 2021

Skylight Health Announces Award of US Clinical Trial

The current healthcare system in the United States is a disaster.

That may be kind; it’s a catastrophe.

Insurance providers are driving a significant change in their reimbursement models to improve health and reduce costs. This shift starts at the source of healthcare: with primary care doctors. Insurance providers are rewarding primary care providers that can transition their business model from the “old model” of fee-for-service (think: high traffic, over-billing, low quality of care) to the “new model” of managed care (think: preventative healthcare on a capitation base).

Despite America’s impressive vaccine drive, if the last year or so has done anything, it’s exposed the American healthcare system for precisely what it is. An overpriced mess. In fact, according to the Centers for Medicare and Medicaid Services (CMS), national health spending is projected to grow at an average annual rate of 5.4% for 2019-28 and potentially reach $6.2 trillion by 2028.(3)

To put in perspective how alarming this is, national health expenditures are projected to outgrow our GDP by an average of 1.1% per year on average over 2019–28.(3) The health share of the economy is also projected to rise from 17.7% in 2018 to 19.7% in 2028.(3)

Further exposing how broken the healthcare system is, primary doctors are overloaded. On average, these doctors can work 51 hours a week and see 20 patients a day.(4)

In addition, according to Mackie Research:

“Approximately 33M Americans remain uninsured mainly due to high costs of insurance coverage, most of which are in low-income families and have at least one worker in the family. People without medical insurance have worse access to care than people who are insured. Those uninsured often face unaffordable medical bills when they seek care. Addressing the high uninsured rate is believed to be an urgent and unmet need in the U.S. healthcare system.”(5)

The U.S. healthcare system operates on a privatized healthcare system, where patients can choose their insurance providers and healthcare packages. However, insurance providers are changing their reimbursement models to increase their revenue by decreasing their payouts on costly services.

The current system, a “fee for service” model, reimburses the client every time they see a doctor.

The newer system, or “value-based model,” reimburses client visits much heavier at the beginning in hopes of preventing expensive surgeries, recurring visits, and more.

There is a healthcare company called Skylight Health Group (TSX:SHG)(OTCQB:SHGFF) at the forefront of this evolution. Skylight is taking a new-age approach that is one of the most innovative and potentially revolutionary I’ve seen thus far to transform our disastrous healthcare system.

On a personal level, I know it when I see it, too. I have family members who work in telemedicine and friends in other aspects of healthcare. I’ve researched healthcare companies and healthcare real estate. I’ve seen this song and dance before with potential disruptors.

What sets Skylight Health apart is its focus on the Primary Care market. Skylight Health has a unique and high-growth business model that acquires “old model” fee-for-service clinics at a discount (3-6x EBITDA).(1) It then overlays their technology, infrastructure and expertise, to transition them to the “new model” of value-based care (10-15x EBITDA).(1)

But the key here? These undervalued “old system” clinics that Skylight acquires are already cash flow positive with high patient retention.

By implementing their expertise and technology, Skylight Health has a dual growth strategy- organic growth and growth through acquisition. Skylight’s business model plans to convert these acquired “old system” clinics to the “new system” while creating immediate arbitrage potential for organic growth.

If the company stopped acquiring healthcare facilities today, they would still likely grow exponentially from organic means alone. However, with more potential acquisitions of undervalued, EBITDA positive clinics in the pipeline, the company’s growth potential through acquisition could be astronomical.

Especially as it prepares to uplist to the Nasdaq.(2)

After all, the company boasts the following:(1)

  • $100mm in acquisition pipeline (priced between 3-7x EBITDA)
  • $56mm revenue run rate
  • Positive EBITDA and positive cash flow from operations
  • No long-term debt and cash balance of $20mm

Skylight has a significant chance to change our entire healthcare system by helping independent and smaller practices adopt a value-based model. With this model, care is measured against quality and outcomes.

With the Primary Care market representing over $290B and growing roughly 4.7% annually(1), the sky’s the limit. When you look at Skylight’s business model, it’s clear that they understand this. Primary Care functions as the gatekeeper of all healthcare services and costs. The core of Skylight’s business realizes that Primary Care practices will need to adapt as the market transitions from fee-for-service to value-based care.

Because most independent practices lack the infrastructure, technology, and capabilities to provide care while measuring value-based capabilities, Skylight Health could have a once-in-a-generation type of opening.

As it readies for its Nasdaq uplisting(2), Skylight has a significant chance to change our entire healthcare system with its goal of helping independent and smaller practices adopt a value-based model where care is measured against quality and outcomes.

Not to mention, this may be one of the largest, yet most undervalued firms in its field.

First and foremost, its patient count is around 155,000 compared to Oak Street Health’s 96,750 and CanoHealth’s 122,000.(1) However, it has roughly 3-6x EBITDA paid compared to CanoHealth’s 10x-15x.(1)

Furthermore, while some of its top competitors have performed well since their IPOs, compared to their forward P/S ratios, Skylight looks by far the most undervalued. Based on data extracted from SEC filings and other sources, consider this.

As the market values these three value-based care competitors in the healthcare industry based on multiples of forward revenue, Oak Street Health is trading over 17x revenue,(6) Agilon over 11x(7), and Privia at over 20x revenue.(23) Meanwhile, SHG is trading at just about 4x 2021 revenue(1).

Not to mention, with Privia just going public days ago, between April 21, 2021-April 30, 2021, the Skylight stock significantly outperformed both Oak Street and Agilon by over 35%.(9)

Take Cityblock Health, a private company with a similar value-based healthcare model as Skylight’s, as another example here. It recently announced the completion of a $160 million Series C funding round and a valuation of over $1 billion.(22)

As Skylight Health prepares to uplist to the Nasdaq, all the signs look immensely bullish for this company’s future. This flourishing company may not be this undervalued for too much longer.

The Top Reasons to Consider Skylight Health Group (TSX:SHG)(OTCQB:SHGFF)

  1. America’s healthcare system has become increasingly expensive and fractured. Significant capital could be rushing towards a Primary Care market representing over $290B with the potential to see an annual growth rate of 4.7%.(1)
  2. Managed/Value-Based Care is an exploding market. In fact, government initiatives helped boost the Value-Based Care Market during the recent health predicament by a rate of almost 50%.(20)
  3. Skylight Health Group (TSX:SHG)(OTCQB:SHGFF) owns and operates primary care practices across 16 states in the U.S., providing care services by virtual telehealth and in person to over 150,000 patients annually.(1)
  4. As it prepares to uplist to the Nasdaq, Skylight Health’s stock has advanced almost 1600% since July(11) while outperforming many of its overvalued competitors.
  5. Based on comparable stock prices and forward P/E ratios, Skylight may be significantly more undervalued than many of its top competitors.
  6. Reflecting how undervalued the company could be, many top analysts, including Raymond James, Beacon Securities, Echelon Capital Markets, Mackie Research, give the company significant upside potential by as much as 53.59%.(1)
  7. The company has a strong balance sheet and a favorable gross profit margin compared to its competitors.(18)
  8. The company’s three-pronged investment strategy, Strategic and Accretive Acquisitions, Strengthen and Enhance Foundation, and Enhance Through New Services and Offerings(1), has it positioned at the forefront of an exploding Managed/Value-Based Care market.
  9. Many of the top insurance conglomerates in the country appear to be adopting Managed/Value-Based Care, including Aetna, which is committed to 75% of claims being value-based by the year 2020.(1)
  10. With organic growth driven by converting to Value-Based Care, Skylight could potentially transform revenue by 500% through instituting infrastructure in technology.(1)
  11. With its playbook and cutting-edge usage of technology and analytics, the company can potentially help independent practices realize their scale and growth potential.(1)
  12. The company has a powerful and dedicated leadership team with an eye towards the future of American healthcare.

Skylight Health Group (TSX:SHG)(OTCQB:SHGFF) Has Bullish Signals All Over It

Ever since the SHG stock bottomed at about $0.09 a share in July 2020, the stock’s moves have been eye-popping. So much so, that despite being slightly off its 12-month peak of about $1.90 a share, it’s seen potentially astronomical upward moves of about 1600% to its current price of roughly $1.53 a share.(11)

Another thing to like about this stock is its big pop potential. With a tiny float of about 134.39 million(12), this is a stock that has the potential to move enormously when it moves. In fact, between April 21-29 alone, the stock’s potentially advanced upwards over 34%.(13)

Additionally, many of its short-, medium-, and long-term indicators look extremely bullish, including its 20-day MA, 20-200 day MACD oscillator, 50-day MA, 50-100 day MACD oscillator, 50-150 day MACD oscillator, 50-200 day MACD oscillator, 100-day MA, 150-day MA, 200-day MA, and its 100-200 day MACD oscillator.(14)

Furthermore, on the fundamental side, the company is reporting some strong highlights for Q4 2020 and fiscal year 2020.(15)

  • Revenue was $3.2 million for the quarter, compared to $3.1 million for Q4 2019. This increase was due to the addition of the acquired clinics during Q4, which offset a slight reduction seen at Skylight’s pre-existing sites.
  • Skylight generated positive cash flow from operations of approximately $156,982 for the year ended December 31, 2020, compared to a loss of $1.1 million for the year ended December 31, 2019.
  • As of December 31, 2020, a significantly strengthened balance sheet is reflected in a cash position of $20 million and a working capital of $18.6 million compared to a cash balance of $0.1 million and a working capital deficiency of $6.7 million on December 31, 2019.
  • In October 2020, the company converted its promissory note held by Merida Capital, extinguishing $4.0 million from its long-term debt.
  • Skylight provided revenue guidance for the full year of roughly $40 million in 2021.

“2020 was a transformative year for Skylight Health. We completed a full rebrand focused on converting our clinics to value-based care, while building a robust pipeline of near-term targets,” said Prad Sekar, Co-Founder and Chief Executive Officer.(15) “We added 6 clinics, strengthened our leadership team, transformed our balance sheet, and made great strides toward transforming our company into a leading multi-state primary care business. We expect to see tremendous growth looking forward as we continue our profitable transition to value-based care across our platform.”(15)

Overall, the company claims an approximately $56 million run rate with over $100 million of revenue in the pipeline, gross margins of 65-75%, targeted operational net margin contribution of 20-30% per clinic, and positive EBITDA and positive cash flow from operations.(1)

Many other fundamental indicators tell you what a potential juggernaut this company could be too. The Altman Z-Score of about 10.8(16) indicates robust financial health and minimal bankruptcy risk. Ideally, companies want a score of 3.0 or higher and no lower than 1.8. The company’s score is over 3.5x the ideal amount, so this is obviously very encouraging.

The company also holds more cash than debt on its balance sheet, as indicated by its current ratio of roughly 7.9x.(17) This tells us that the company potentially has nearly 8 times more current assets than current liabilities. Not to mention, the company claims no long-term debt and a cash balance of about $20 million.(1)

Furthermore, according to Finbox, the company’s latest twelve-month gross profit margin is about 68.7%.(18) This may compare extremely favorably with the overall healthcare sector and its top competitors as deemed by Finbox.

Lastly, Finbox states that Skylight Health’s net income growth forecast is 67.1%.(19) It also says that the net income growth forecast is expected to average 16.8%, with median net income growth of about 45.2% over the next five fiscal years.(19)

When you consider these factors all working in the company’s favor, it’s not too shocking to see that many analysts give the company bullish price targets. In fact, from the stock’s current position of about $1.53 a share, it may have upside potential as high as 53.59%, according to some of the following price targets.(1)

  • Raymond James $2.25
  • Beacon Securities $2.35
  • Echelon Capital Markets $2.35
  • Mackie Research $2.10

Who is Skylight Health Group (TSX:SHG)(OTCQB:SHGFF)

The mission statement of Skylight Health Group is the following:

“Skylight Health has returned US healthcare to the way it should be – highly accessible and highly affordable.”(10)

Skylight Health owns and operates primary care practices across 16 states in the US, providing care services by virtual telehealth and in-person to over 150,000 patients annually.(1)

Skylight has rebranded itself into a company with an eye towards the future of Primary Care with a Value-Based Medicine Model. The foundations of Skylight’s business model are the following:

1) Fee For Service

Reimbursement for Episodic Care through public or private payor systems.

2) Primary Care Cap with Incentive Bonuses

Monthly fee based on market ($40-$75 per member) and incentives.

3) Primary Care Cap with a Percentage of Shared Savings 

Reimbursement of 10% to 50% based on savings on hospital costs, outpatient care, pharmacy spend, etc.

4) Limited Risk Agreement

Continued share of savings on hospital costs, outpatient care, pharmacy spend, etc.

5) Full Risk Agreement

Become fully at risk for all primary care expenses including medical claims, specialty claims, etc. And share in the savings on hospital care and potential for additional share in savings on pharmacy spend.

6) Global Risk

Become fully at risk for all primary care expenses including medical claims, specialty claims, etc.

As well as full risk for all pharmacy spend.

The goal of the company is for all of these factors to connect and evolve as relationships and trust with different payors strengthens.

The company also has a three-pronged investment strategy:(1)

1) Strategic and Accretive Acquisitions 

Pipeline of deals over $100mm+ in revenue priced between 3-7x EBITDA. The company also has about $20 million cash on hand in order to help execute this prong of its growth strategy.

Weeks ago, Skylight Health completed the acquisition of Primary Care Clinic Group, Rocky Mountain Health Care.(21) With this deal, Skylight Health owns a valuable Primary Care asset with roughly 7 locations in the Denver and Boulder areas. The agreement also strengthens the executive team with a robust, centralized corporate infrastructure. Not to mention, Skylight Health expects the forecasted annual revenue run rate to be about CA$56M pending the closing of all announced acquisitions.(21)

2) Strengthen and Enhance Foundation 

People, process and quality improvements lead to immediate revenue growth.

3) Enhance Through New Services and Offerings

Leverage data and insights to create new growth opportunities from accretive services.

At The Forefront of a Rapidly Growing Medical Sector

Managed/Value-Based Care is an exploding market.  In fact, government initiatives helped boost the Value-Based Care Market during the recent health predicament by a rate of almost 50%.(20)

Furthermore, consider these quotes from some of the largest health insurance conglomerates in the United States, indicating that Value-Based Care could be the future of medicine.(1)

  • “This model allows physicians to focus time and energy on those patients who need the most support to stay well at home, and out of the hospital. Physicians are clearly seeing the benefit of improved patient outcomes and more shared savings.”- Ray A. Bevridge Chief Medical Officer, Humana
  • “The pay-per-value model — rewarding groups of providers to keep people well and healthy — is far more powerful than the traditional fee-for-service model.”-Wyatt W. Deck, CEO OptumHealth
  • “Aetna is committed to 75% of claims being value-based by the year 2020. And care management is widely known as a good strategy to improve health and reduce costs.” -Mohamed Diab, VP Provider Transformation Aetna

Plus, with organic growth driven by converting to Value-Based Care, Skylight could potentially transform revenue by 500% through instituting infrastructure in technology.(1)

By deploying the Skylight Health playbook focusing on Operations & Finance, Revenue  Cycle, Quality & Clinical, and Technology, the company may also help independent practices realize their scale while centralizing and managing through a single platform.(1)

Skylight Health Group (TSX:SHG)(OTCQB:SHGFF) Could See Further Growth Thanks to Cutting Edge Analytics & Research

The company may have found yet another lane for it to genuinely corner a rapidly growing market. This could be through the way it’s advanced safety and efficacy research surrounding alternative health treatments by monitoring and assessing real-world data (RWD) and providing real-world evidence (RWE).

Skylight has designed, developed, and acquired secure and compliant proprietary technology and digital assets which specialize in monitoring, assessing, and evaluating patient treatment plans at the point of care. This primary technology platform, Sail, is a proprietary electronic database management platform.(1)

Skylight has also amassed one of the industry’s largest patient registries seeking out conventional and non-conventional treatments.(1)

With this foray into technology and analytics, the potential for the company to integrate with Value Care Models could be potentially historic.

Strong Leadership, Strong Results

Successful companies tend to possess common traits, and one of those traits is a strong management team. Skylight Health Group (TSX:SHG)(OTCQB:SHGFF) certainly has that ground covered.

Prad Sekar
Chief Executive Officer, Secretary and Director

Mr. Sekar has spent over 15 years in clinical practice management, owning, operating, and consulting with outpatient multidisciplinary healthcare practices in Canada and the US. Mr. Sekar holds a BSc Hon from the University of Ottawa and an MBA from Hult International Business School. Following a career in establishing and operating successful medical practices, Mr. Sekar began consulting with Canadian medical regulatory bodies and agencies to support their network of practitioners in the establishment and operation of medical clinics. Mr. Sekar is also a recognized professor with a registered program for Medical Office Assistants under the Ontario Ministry of Education.

Kash Qureshi
President, Chief Technology Officer, and Director

As co-founder of CB2 Insights, Mr. Qureshi brings more than 20 years of extensive operational and entrepreneurial experience in sales, commercial financing, technology, and the last 10 years directly involved in healthcare, wellness, and health technology. An ardent cost-efficiency executive, Mr. Qureshi has focused on technology infrastructure, operational proficiencies, overall profitability, as well as acquisitions in a series of organizations throughout the healthcare sector.

Andrew Elinesky
Chief Financial Officer

A well-tenured financial professional, Mr. Elinesky brings over 20 years of experience as a CFO and senior financial leader for publicly traded companies in Canada and the US.  With a focus on M&A and consolidation experience, Andrew was SVP and CFO at McEwen Mining. There, he managed equity and debt financing of over $150M and a $35M asset acquisition and $40M company acquisition.  He also has held various senior leadership and treasury roles at Heinz UK, Diageo, and Worldcom UK.  Andrew graduated from Oxford Brookes University and is Treasurer for the Canadian Network for the Prevention of Elder Abuse.

Dr. Georges Feghali
Chief Medical Officer

Dr. Feghali brings over 30 years of clinical expertise and more than 20 years of senior leadership experience to the team. He spent 17 years with TriHealth as Chief Medical Officer and COO of Emirates Hospitals Group (now Emirates Healthcare). Dr. Feghali has been responsible for the quality, safety, and healthcare service for multiple organizations with over $1B in revenue.

Paul Kulas
Chief Operating Officer

Paul brings a diverse set of healthcare expertise, having been VP Operations for St. Joseph Health Medical Group, which has over 120,000 caregivers across 51 hospitals and more than 1,000 clinics.  He was instrumental in implementing the organization’s telehealth services and other new technologies.  He holds a Master of Science in Administration from Central Michigan University.

Dan Thompson
Chief Corporate Officer

Dan brings over 20 years of marketing experience with high-growth public and private technology companies. Dan built and led the marketing divisions for early-stage companies in retail, travel, and payment technology. Dan graduated from Michigan State University with degrees in marketing and communications.

Pam Galassini
Chief Business Development Officer

Pam has over 20 years of experience in the pharmacy benefit management, insurance payor insights, and pharmaceutical manufacturing industries. Ms. Galassini works to open up channels to bridge patient needs with insurance capabilities.  Before joining Skylight Health, she was with Medco Health Solutions.

Stephanie Gluchacki
SVP, Compliance

With over a decade of experience in the US healthcare market, Ms. Gluchacki has led the multi-state management of multiple medical clinics and clinic brands in both the primary care and specialty medicine space.  She brings an acute focus to governance, regulations, and financial management, having served as President of Clinical Operations for a significant U.S. clinic brand.

Board of Directors

Patrick McNamee
Chairman of the Board

Patrick brings substantial healthcare leadership, having been EVP and COO of Express Scripts. At Express Scripts, he led all major activities of the technology-driven pharmacy benefit management company.  With a focus on organic and acquisitive growth, McNamee was instrumental in bringing the company from $3B in revenue to over $120B.  He is also the former President and CEO of Health Insurance Innovations. He led a significant and fast turnaround, increasing the share price from $4 to $58 in less than 2 years.

Norton Singhavon

Norton is the Founder, Chairman & CEO of GTEC Holdings. He has extensive capital investments, acquisitions, consolidations, and start-up experience in Canada’s private and public green leaf sector. He has deployed over $100 million into the North American green leaf industry and has been involved in numerous public M&A green leaf transactions, and was an early-stage advisor to major Licensed Producers, including Cronos Group.

Grace Mellis

Grace brings nearly three decades of strategy, finance, and capital markets experience with executive roles at JP Morgan Chase, including Head of International Strategy and as Investor Services CFO for EMEA.  Ms. Mellis is also the former Chief Financial Officer at Greendot Corporation, a US$3.1B market cap NYSE-listed company.  She is also a mentor and investor with Techstars, a global start-up incubation platform.

Peter Cummins

Peter has spent over two decades with Johnson & Johnson, including executive leadership roles overseeing research and development, product development, external innovation, regulatory affairs, and hospital pharmacy across Canada, the U.S., Europe, and other regions. He has also served in Regulatory and Scientific Affairs at Procter & Gamble and was the Director of Pharmacy at Cambridge Memorial Hospital.

Tom Brogan

Tom Brogan brings 40 years of experience in aggregating anonymized healthcare data to create insights to support traditional pharmaceutical companies and health economic studies.  His innovations include a long list of applications that merge Real World Evidence with traditional healthcare protocols. Mr. Brogan is currently the CEO and Chairman at Vestrum Health, an electronic healthcare record data company. Vestrum delivers information systems to pharmaceutical manufacturers, physician practices, and other healthcare stakeholders. Before Vestrum Health, he was the founder of Brogan Consulting, which was acquired by IMS in 2010. It is now IQVIA, one of the world’s largest Contract Research Organizations (CROs). Mr. Brogan continued on with the company as Vice President of Global Oncology at IMS Health.

Prad Sekar

Mr. Sekar has spent over 15 years in clinical practice management, owning, operating, and consulting with outpatient multidisciplinary healthcare practices in Canada and the US. Mr. Sekar holds a BSc Hon from the University of Ottawa and an MBA from Hult International Business School. Following a career in establishing and operating successful medical practices, Mr. Sekar began consulting with Canadian medical regulatory bodies and agencies to support their network of practitioners in the establishment and operation of medical clinics. Mr. Sekar is also a recognized professor with a registered program for Medical Office Assistants under the Ontario Ministry of Education.

Kash Qureshi

As co-founder of CB2 Insights, Mr. Qureshi brings more than 20 years of extensive operational and entrepreneurial experience in sales, commercial financing, technology, and the last 10 years directly involved in healthcare, wellness, and health technology. An ardent cost-efficiency executive, Mr. Qureshi has focused on technology infrastructure, operational proficiencies, overall profitability, as well as acquisitions in a series of organizations throughout the healthcare sector.

The Top Reasons to Consider Skylight Health Group (TSX:SHG)(OTCQB:SHGFF)

  1. America’s healthcare system has become increasingly expensive and fractured. Significant capital could be rushing towards a Primary Care market representing over $290B with the potential to see an annual growth rate of 4.7%.(1)
  2. Managed/Value-Based Care is an exploding market. In fact, government initiatives helped boost the Value-Based Care Market during the recent health predicament by a rate of almost 50%.(20)
  3. Skylight Health Group (TSX:SHG)(OTCQB:SHGFF) owns and operates primary care practices across 16 states in the U.S., providing care services by virtual telehealth and in person to over 150,000 patients annually.(1)
  4. As it prepares to uplist to the Nasdaq, Skylight Health’s stock has advanced almost 1600% since July(11) while outperforming many of its overvalued competitors.
  5. Based on comparable stock prices and forward P/E ratios, Skylight may be significantly more undervalued than many of its top competitors.
  6. Reflecting how undervalued the company could be, many top analysts, including Raymond James, Beacon Securities, Echelon Capital Markets, Mackie Research, give the company significant upside potential by as much as 53.59%.(1)
  7. The company has a strong balance sheet and a favorable gross profit margin compared to its competitors.(18)
  8. The company’s three-pronged investment strategy, Strategic and Accretive Acquisitions, Strengthen and Enhance Foundation, and Enhance Through New Services and Offerings(1), has it positioned at the forefront of an exploding Managed/Value-Based Care market.
  9. Many of the top insurance conglomerates in the country appear to be adopting Managed/Value-Based Care, including Aetna, which is committed to 75% of claims being value-based by the year 2020.(1)
  10. With organic growth driven by converting to Value-Based Care, Skylight could potentially transform revenue by 500% through instituting infrastructure in technology.(1)
  11. With its playbook and cutting-edge usage of technology and analytics, the company can potentially help independent practices realize their scale and growth potential.(1)
  12. The company has a powerful and dedicated leadership team with an eye towards the future of American healthcare.
Source 1: https://skylighthealthgroup.com/view-presentation/
Source 2: https://www.globenewswire.com/news-release/2021/04/22/2215603/0/en/Skylight-Health-Files-Preliminary-Base-Shelf-Prospectus.html
Source 3: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet
Source 4: https://www.physicianleaders.org/news/how-many-patients-can-primary-care-physician-treat
Source 5: https://www.mackieresearch.com/client/research/document/24075?verif=4c58093ebec94706118e2dbc1be121e9ece09463&o=a8bc0b52
Source 6: https://ca.finance.yahoo.com/news/oak-street-health-inc-nyse-050710424.html
Source 7: https://sec.report/Document/0001193125-21-085566/
Source 8: https://finbox.com/TSXV:SHG
Source 9: https://stockcharts.com/freecharts/perf.php?SHG.V,OSH,AGL,
Source 10: https://skylighthealthgroup.com/mission/
Source 11: https://stockcharts.com/h-sc/ui?s=SHG.V&p=D&yr=1&mn=0&dy=0&id=p94466689760&a=946300625&listNum=3
Source 12: https://finance.yahoo.com/quote/SHGFF/key-statistics?p=SHGFF
Source 13: https://stockcharts.com/freecharts/perf.php?SHG.V
Source 14: https://www.barchart.com/stocks/quotes/SHG.VN/opinion
Source 15: https://www.biospace.com/article/skylight-health-group-announces-fourth-quarter-and-full-year-2020-results-/
Source 16: https://finbox.com/OTCPK:SHGF.F/explorer/altman_z_score
Source 17: https://finbox.com/OTCPK:SHGF.F/explorer/current_ratio
Source 18: https://finbox.com/OTCPK:SHGF.F/explorer/gp_margin
Source 19: https://finbox.com/OTCPK:SHGF.F/explorer/ni_proj_growth
Source 20: https://bit.ly/3t7uwte
Source 21: https://www.globenewswire.com/en/news-release/2021/04/05/2204190/0/en/Skylight-Health-Completes-Acquisition-of-Primary-Care-Clinic-Group-Rocky-Mountain-with-7-Locations-in-Colorado.html
Source 22: https://hitconsultant.net/2020/12/10/cityblock-health-1b-valuation-funding/#.YGs9OC1h1R1b
Source 23: https://sec.report/Document/0001193125-21-135346/

Legal Disclaimer


This website / media webpage is owned, operated and edited by TD Media LLC. Any wording found on this website / media webpage or disclaimer referencing to “I” or “we” or “our” or “TD Media” refers to TD Media LLC. This website / media webpage is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to market and promote small public companies. By reading our website / media webpage you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis for making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our website / media webpage.We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website / media webpage are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our website / media webpage may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. TD Media business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our Websites, Email, SMS, Push Notifications, Influencers, Social Media Postings, Ticker Tags, Press Releases, Online Interviews, Podcasts, Videos, Audio Ads, Banner Ads, Native Ads, Responsive Ads. This compensation is a major conflict of interest in our ability to be unbiased regarding. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, TD Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.

INFLUENCER COMPENSATION

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 12/03/2020 and ending on 12/03/2020 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have paid this Influencer seven hundred fifty dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 03/09/2021 and ending on 03/09/2021 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have paid this Influencer one thousand five hundred dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 04/05/2021 and ending on 04/05/2021 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have paid this Influencer five hundred dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 04/05/2021 and ending on 04/09/2021 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have paid this Influencer one hundred ninety five dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 04/05/2021 and ending on 04/05/2021 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have paid this Influencer one thousand dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 05/04/2021 and ending on 05/06/2021 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have paid this Influencer five hundred dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 05/05/2021 and ending on 05/05/2021 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have paid this Influencer one thousand five hundred dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 05/06/2021 and ending on 05/06/2021 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have paid this Influencer one thousand dollars USD.

COMPENSATION

Pursuant to an agreement between TD Media LLC and Winning Media LLC, TD Media LLC has been hired for a period beginning on 11/30/2020 and ending on 12/31/2020 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have been paid two hundred fifty thousand dollars USD via bank wire transfer.

Pursuant to an agreement between TD Media LLC and Winning Media LLC, TD Media LLC has been hired for a period beginning on 01/01/2021 and ending on 01/24/2021 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have been paid an additional two hundred thousand dollars USD via bank wire transfer. We own zero shares of (SHGFF:US) (SHG:CA). To date we have been paid four hundred fifty thousand dollars USD via bank wire transfer. To disseminate information about (SHGFF:US) (SHG:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and Winning Media LLC, TD Media LLC has been hired for a period beginning on 01/25/2021 and ending on 01/29/2021 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have been paid an additional fifty thousand dollars USD via bank wire transfer. We own zero shares of (SHGFF:US) (SHG:CA). To date we have been paid five hundred thousand dollars USD via bank wire transfer. To disseminate information about (SHGFF:US) (SHG:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and Winning Media LLC, TD Media LLC has been hired for a period beginning on 03/02/2021 and ending on 03/15/2021 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have been paid an additional sixty thousand dollars USD via bank wire transfer. We own zero shares of (SHGFF:US) (SHG:CA). To date we have been paid five hundred sixty thousand dollars USD via bank wire transfer. To disseminate information about (SHGFF:US) (SHG:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and Winning Media LLC, TD Media LLC has been hired for a period beginning on 03/12/2021 and ending on 04/08/2021 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have been paid an additional one hundred thousand dollars USD via bank wire transfer. We own zero shares of (SHGFF:US) (SHG:CA). To date we have been paid six hundred sixty thousand dollars USD via bank wire transfer. To disseminate information about (SHGFF:US) (SHG:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and Winning Media LLC, TD Media LLC has been hired for a period beginning on 05/03/2021 and ending on 05/14/2021 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have been paid an additional fifty thousand dollars USD via bank wire transfer. We own zero shares of (SHGFF:US) (SHG:CA). To date we have been paid seven hundred ten thousand dollars USD via bank wire transfer. To disseminate information about (SHGFF:US) (SHG:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and Winning Media LLC, TD Media LLC has been hired for a period beginning on 05/17/2021 and ending on 05/21/2021 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have been paid an additional twenty five thousand dollars USD via bank wire transfer. We own zero shares of (SHGFF:US) (SHG:CA). To date we have been paid seven hundred thirty five thousand dollars USD via bank wire transfer. To disseminate information about (SHGFF:US) (SHG:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and Winning Media LLC, TD Media LLC has been hired for a period beginning on 05/27/2021 and ending on 06/02/2021 to publicly disseminate information about (SHGFF:US) (SHG:CA) via digital communications. We have been paid an additional twenty five thousand dollars USD via bank wire transfer. We own zero shares of (SHGFF:US) (SHG:CA). To date we have been paid seven hundred sixty thousand dollars USD via bank wire transfer. To disseminate information about (SHGFF:US) (SHG:CA) via digital communications.

Skylight Health Group

Skylight Health Group is a health care services and technology provider focusing on providing both onsite and telemedicine services. With a network of over 30 primary and urgent care clinics across 13 states, Skylight also has a patient base exceeding 110,000 people. In addition, Skylight Health offers a subscription-based healthcare model for uninsured Americans, and a traditional fee-for-services model for insured patients covered by Medicare, Medicaid and other commercial plans.